Cas:56246-88-9 2-amino-2-(4-hydroxy-3-methoxyphenyl)acetic acid manufacturer & supplier

Chemical Name:2-amino-2-(4-hydroxy-3-methoxyphenyl)acetic acid

CAS.NO:56246-88-9

Synonyms:2-amino-2-(4-hydroxy-3-methoxyphenyl)acetic acid

Molecular Formula:C₉H₁₁NO₄

Molecular Weight:197.18800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:92.78000

Exact Mass:197.06900

LogP:1.18550

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-amino-2-(4-hydroxy-3-methoxyphenyl)acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-amino-2-(4-hydroxy-3-methoxyphenyl)acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-amino-2-(4-hydroxy-3-methoxyphenyl)acetic acid Use and application,2-amino-2-(4-hydroxy-3-methoxyphenyl)acetic acid technical grade,usp/ep/jp grade.

Related News: Considering that small batches present a challenge in proving the robustness of the processing equipment, the Alcami project team, in collaboration with client team members, prepared a failure mode, effects, and criticality analysis (FMECA) of the formulation and process. (Z)-7-((1R,2S,3S,4S)-3-(5-(benzofuran-3-ylmethyl)thiophene-2-carboxamido)bicyclo[2.2.1]heptan-2-yl)hept-5-enoic acid manufacturers So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off. N-((1-((8-cyano-2,3-dihydro-7H-[1,4]dioxino[2,3-e]indol-2-yl)methyl)piperidin-4-yl)methyl)picolinamide suppliers The announcement comes on top of Recipharm’s move into Morocco, which was fueled by local pledges of $500 million. The new facility under construction and due for completion in 2023 will employ 300 and have a capacity of 300 million units annually. [1-(trimethylsilyl)vinyl]magnesium bromide vendor & factory So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off.,The announcement comes on top of Recipharm’s move into Morocco, which was fueled by local pledges of $500 million. The new facility under construction and due for completion in 2023 will employ 300 and have a capacity of 300 million units annually.